Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotechnology Value Fund, L.P. -- Ignore unavailable to you. Want to Upgrade?

To: RCMac who wrote (732)	6/22/1999 1:41:00 AM
From: aknahow	Read Replies (1) \| Respond to of 4974

Thanks, tried to thank you earlier, but screen froze. I agree with your thoughts on takeovers and that with biotechs they are more likely to be friendly. However even in friendly mergers a position is usually accumulated before the partner says yes. TMO, which I do not own, would actually sell its holdings if rebuffed. For Synaptic one can see the same 13 D on both the BVF SEC listing and the Synaptic S.E.C. listing. As you indicate it would not be logical that a company would be required to file to report the shareholdings of a hostile party when they might not even be aware of them, and thus could not report within the required time period. But perhaps the S.E.C. index system pull up these reports on an either/or basis. If you search the hostile party you get the filing but if you search the target you also get it.